Biobot Surgical, an innovator in robotic-assisted prostate disease management, is proud to announce that the Mona Lisa 2.0 has received CE Certification, adding to the US FDA, Australia TGA and Singapore HSA approvals. This milestone paves the way for Mona Lisa 2.0 to be utilized in clinical settings across an additional 32 countries, bringing its revolutionary features to urologists and their patients.